Paper20207771
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers.
Sturgeon CM and 17 others. Clin Chem, 2010. Cited by 152 papers, by iCite.
Cite this record
ConductScience Library. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers. Papers, record 20207771. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20207771
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Clinical Laboratory Techniques | Major topic |
| Liver Neoplasms | Major topic |
| Stomach Neoplasms | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Uterine Cervical Neoplasms | Major topic |
| Female | |
| Humans | |
| alpha-Fetoproteins |
Source PubMed
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 152 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41634619 | Prognostic stratification in gastric cancer with peritoneal metastasis: tumor biology and diagnostic modality as a surrogate for disease burden. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41634619 | PubMed |
| 41025051 | Establishment and verification of a nomogram model based on the inflammatory indicators of patients with cervical cancer for predicting the risk of their lymph node metastasis. | PeerJ | 2025 | https://conductscience.org/library/papers/41025051 | PubMed |
| 40723883 | The Future of Tumor Markers: Advancing Early Malignancy Detection Through Omics Technologies, Continuous Monitoring, and Personalized Reference Intervals. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723883 | PubMed |
| 38946049 | Phenotypical and biochemical characterization of murine psoriasiform and fibrotic skin disease models in Stabilin-deficient mice. | FEBS Open Bio | 2024 | https://conductscience.org/library/papers/38946049 | PubMed |
| 38898088 | A plug-and-play, easy-to-manufacture fluidic accessory to significantly enhance the sensitivity of electrochemical immunoassays. | Sci Rep | 2024 | https://conductscience.org/library/papers/38898088 | PubMed |
| 37835844 | Method Comparison and Clinical Performance of Breast Cancer Tumor Markers on Novel Multiplex Immunoassay and Automatized LOCI Technology Platforms. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37835844 | PubMed |
| 37476184 | A preoperative prediction of lymph node metastasis in early cervical squamous cell cancer with hematologica - based model. | J Cancer | 2023 | https://conductscience.org/library/papers/37476184 | PubMed |
| 37430160 | Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37430160 | PubMed |
| 37370914 | Longitudinal Evaluation of AFP and CEA External Proficiency Testing Reveals Need for Method Harmonization. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37370914 | PubMed |
| 36505781 | Data-independent acquisition mass spectrometry identification of extracellular vesicle biomarkers for gastric adenocarcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/36505781 | PubMed |
| 36230569 | Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230569 | PubMed |
| 34886853 | Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer. | World J Surg Oncol | 2021 | https://conductscience.org/library/papers/34886853 | PubMed |
| 34727105 | Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study. | PLoS One | 2021 | https://conductscience.org/library/papers/34727105 | PubMed |
| 34217251 | Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma. | BMC Cancer | 2021 | https://conductscience.org/library/papers/34217251 | PubMed |
| 33833581 | Histogram Analysis of Diffusion-Weighted Magnetic Resonance Imaging as a Biomarker to Predict Lymph Node Metastasis in T3 Stage Rectal Carcinoma. | Cancer Manag Res | 2021 | https://conductscience.org/library/papers/33833581 | PubMed |
| 33780049 | The potential diagnosis role of TP53 mutation in advanced bladder cancer: A meta-analysis. | J Clin Lab Anal | 2021 | https://conductscience.org/library/papers/33780049 | PubMed |
| 33575904 | Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer. | J Gastrointest Surg | 2021 | https://conductscience.org/library/papers/33575904 | PubMed |
| 33356502 | Evaluation of 2 Commercially Systems for Detection of Serum Squamous Cell Carcinoma Antigen in Pan Squamous Cell Carcinoma. | Cancer Control | 2020 | https://conductscience.org/library/papers/33356502 | PubMed |
| 33097814 | Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening. | Sci Rep | 2020 | https://conductscience.org/library/papers/33097814 | PubMed |
| 33061563 | The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33061563 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20207771
GET https://conductscience.org/api/papers/v1/20207771/cited_by?page=2